Abluminus DES+ | plus medica GmbH - plusmedica.de

Abluminus DES+

Sirolimus coated stent

ABLUMINUS DES+ was developed from the proprietary ENVISOLUTION technology to address unmet clinical needs in patients with diabetes mellitus and acute myocardial infarction with coronary artery disease.


  • • Sirolimus acts cytostatic - not cytotoxic
  • • Optimum Sirolimus binding to the balloon surface thanks to Nanolute technology
  • • 100% balloon coating
  • • Slow tissue absorption
  • • Effective Sirolimus transfer into deeper vessel layers
  • • High Sirolimus bioavailability


Abluminal Coating
Facilitate mono directional drug release and less systemic exposure of drug leading to faster re-endothelistation

Fusion Coating
Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis

Edge Coating
The additional 0.5mm coating on the edge of the balloon which addresses the edge restenosis

Biodegradable Film
The formation of circular film with biodegradable polymer facilitate maximum drug delivery in blood wet conditions

Abluminus DES+ Brochure

Additional Information

For more information about this product click here

Other products



Atherectomy Catheter



Venous Stent